Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
The article warns that hindsight bias distorts clinical medicine by making adverse outcomes appear inevitable after the fact. Physicians often face ambiguous symptoms, limited data, and time pressure, yet retrospective reviews rewrite cases as if certainty existed from the start. This cognitive trap conflates reasonable judgment with negligence, prompting unfair criticism of clinicians. The resulting pressure drives defensive practices, unnecessary testing, and erodes trust in medical decision‑making.
A Neurology study of 3,910 former college athletes found that those with three or more lifetime concussions exhibited significantly higher anxiety, depression, and related symptom scores five years after graduation. About 36% of participants reported at least one concussion, and...
CVS Health announced a proposed settlement with the Federal Trade Commission concerning its insulin pricing practices. The agreement, negotiated by CVS’s pharmacy benefit manager Caremark, is modeled after the FTC’s recent deal with Express Scripts, a Cigna subsidiary. While the...
The American College of Physicians (ACP) has issued version 3 of its outpatient COVID‑19 treatment guideline, focusing on antiviral therapy for high‑risk patients and retiring the guideline’s living status after four years of continuous review. It recommends nirmatrelvir/ritonavir (Paxlovid) and molnupiravir...
Researchers analyzed real‑world claims data from 12,245 Crohn’s disease patients treated between 2016 and 2022 to compare safety outcomes across five advanced therapies, including TNF antagonists, vedolizumab, ustekinumab, risankizumab, and upadacitinib. Incidence rates for serious infections, major adverse cardiovascular events,...
Leeds Teaching Hospitals NHS Trust has opened a free, midwife‑led drop‑in workshop called Meet the Midwives, running every Monday at the Leeds Baby Bank Hub. The service provides practical advice on housing, benefits, infant care and mental‑health support for pregnant...
Digital health company CaryHealth announced a strategic partnership with digital pharmacy services provider HealthDyne to reinforce its direct-to-patient platform. The collaboration leverages CaryHealth’s AI-driven prescription intake and patient support with HealthDyne’s nationwide, cold-chain‑enabled pharmacy infrastructure, creating a redundant, scalable fulfillment...
Ping An Healthcare and Technology Co. Ltd announced a full‑year net profit of RMB379.5 million, a 366% increase from the prior year, while revenue climbed 13.7% to RMB5.468 billion. The results highlight accelerating adoption of its telemedicine and digital health platform across...
Kintor Therapeutics announced that its oral JAK inhibitor KX-826 successfully met both primary and key secondary endpoints in a pivotal Phase III trial for alopecia areata. The double‑blind study enrolled 620 patients and showed statistically significant hair regrowth compared with...
The FDA sent a March 13 warning letter to ImmunityBio, a company controlled by biotech magnate Patrick Soon‑Shiong, after finding multiple false and misleading statements about its bladder‑cancer drug Anktiva. The agency highlighted that television ads and a podcast claimed the...
A randomized trial of 22 oncologists and primary‑care physicians showed that eight weeks of using the Knowtex AI scribe increased average daily patient visits from 16.6 to 18.4 and boosted total fees per day by roughly $800. Clinicians reported an...
‘Armchair Anonymous’ aired an episode where anonymous first responders recounted some of their most intense field calls, ranging from a helicopter crew treating a traumatic amputation to a Canadian firefighter rescuing a man trapped under a car. The stories highlighted...
Ocugen announced that its investigational gene therapy for geographic atrophy, a leading cause of vision loss in age‑related macular degeneration, will move into a Phase 3 clinical trial. The company reported mixed Phase 2 results, showing a favorable safety profile but inconsistent...
Birmingham Women’s and Children’s NHS Foundation Trust has introduced Aria, an AI‑driven mental‑health platform, to give staff 24/7 confidential support. The app aims to curb burnout‑related sickness absence, a major driver of lost workdays in the NHS. Early usage shows...
Farzad Mostashari, former US national coordinator for health IT, reflects on the chaotic rollout of electronic health records (EHR) and draws parallels to today’s AI hype in healthcare. He argues that the last health‑tech revolution exposed systemic flaws—interoperability gaps, clinician...
The Centers for Medicare & Medicaid Services is weighing a policy that would automatically enroll seniors into a Medicare Advantage (MA) plan, shifting the default from traditional fee‑for‑service Medicare. CMS officials say beneficiaries could still opt out or select a...
The Defense Health Agency’s Military Medical Malpractice Claims Appeals Board denied the family’s lawsuit over the death of Specialist Maria Martinez, ruling the Pentagon bears no liability. The board concluded that even a five‑month earlier diagnosis would not have altered...
The U.S. Food and Drug Administration issued a warning to ImmunityBio after a television ad and a podcast featuring billionaire biotech entrepreneur Patrick Soon‑Shiong suggested that the company’s bladder‑cancer drug Anktiva could cure or prevent all cancers. The FDA said...
Ambient AI scribes are the biggest breakthrough in clinical documentation in a decade. They will absolutely cure the charting backlog. But they will introduce a much more dangerous form of physician burnout. Dr. Dike Drummond explains the incoming crisis. Right now, clinical...
Researchers at HU School of Pharmacy found that the non‑psychoactive cannabinoids cannabidiol (CBD) and cannabigerol (CBG) can remodel liver metabolism, enhancing energy storage and lysosomal function. In mouse models of metabolic dysfunction associated steatotic liver disease (MASLD), both compounds lowered...
University of California, San Diego researchers introduced a physics‑based model that quantifies the sensitivity limits of competitive lateral flow assays (cLFAs). By applying the model, they engineered fentanyl test strips that are roughly 100 times more sensitive than existing commercial...
The article provides a practical checklist for patients seeking a dental implant specialist who leverages digital tools such as 3D imaging, AI‑driven treatment planning, and guided surgery, with a focus on Miami practices. It highlights the importance of advanced imaging,...
The Academy of International Mobile Healthcare Integration announced the winners of its 2026 Excellence in EMS Integration Awards. Recipients include Sonoma County Fire District EMS, Rep. Mike Carey, Medic Keep the Beat Foundation, Prisma Health Ambulance Service, Justin Duncan, and...
KeyCare, the nation’s only Epic‑based virtual care group, has launched NVIDIA’s Nemotron large language model in production to power its AI‑driven patient intake agent. The agent, embedded in KeyCare’s virtual waiting room, captures and summarizes clinically relevant Epic data before...
Alnylam Pharmaceuticals announced a strategic partnership with Viz.ai to develop an AI‑enabled care pathway for earlier detection of transthyretin amyloid cardiomyopathy (ATTR‑CM), launching the AWARE study in five health systems. The company also pledged support for the American Heart Association’s...
Karyopharm reported mixed results from its Phase 3 SENTRY trial of selinexor in myelofibrosis, achieving a statistically significant reduction in spleen volume but raising safety concerns. The data fell short of expectations for overall survival benefit. Meanwhile, Rezolute announced it will...
I’m excited a new noninvasive way to evaluate endothelial function. Stay tuned for a deeper dive as I test it on myself. https://www.vendys2.com/drlufkin VENDYS_2
Two recent lawsuits illustrate the deadly cost of ignoring vasovagal syncope during phlebotomy. In Georgia, a medical assistant left a truck driver upright on an exam table despite dizziness, resulting in a broken neck and a $15 million verdict for lifetime...
A federal district court in Massachusetts issued a temporary stay halting HHS Secretary Robert F. Kennedy Jr.'s sweeping overhaul of the U.S. childhood vaccine schedule. The judge ruled the changes violate the Administrative Procedure Act because Kennedy replaced career experts...
Amidst the SaaS bloodbath fears, is health tech actually safer than people think? I sat down with @SeanDuffy (CEO of @OmadaHealth) and Stephanie Davis (Healthcare Industry Analyst) to dig into what's really happening in the markets and what it means for...
OnMed has been named to Fast Company’s World’s Most Innovative Companies list for 2026, earning a No. 14 ranking in North America. The company’s AI‑enabled CareStation™ platform has expanded into rural states, schools, an airport hub, and Puerto Rico over the...
T‑cell engagers are bispecific antibodies that redirect T cells to destroy cancer cells and are being explored for autoimmune disorders. Seven companies are leading the field: Adaptin Bio secured FDA IND clearance for APTN‑101 in glioblastoma; Candid Therapeutics merged with...
CVS has begun locking darker foundation and concealer shades behind anti‑theft devices, citing shoplifting data rather than racial intent. Retail theft in the U.S. surged 19 percent year‑over‑year, with projected losses near $48 billion for 2026, prompting chains to protect high‑risk items....
The Longevity Medicine Patient Experience Framework: A Seven-Domain Model for Optimizing Person-Centered Longevity Medicine "By operationalizing a patient-experienced, person-centered approach, this framework offers potential solutions to common challenges in longevity medicine, including care fragmentation, accessibility barriers, and poor patient engagement. It...
Nutritionists and obesity physicians say GLP‑1 drugs such as Wegovy and Zepbound only deliver lasting weight loss when paired with a high‑protein, high‑fiber, well‑hydrated diet. With roughly one in eight U.S. adults on these medicines and more than 600,000 Wegovy‑pill...
A senior Trump administration health official warned that the president’s most‑favored‑nation (MFN) drug‑pricing strategy may unintentionally raise prices abroad rather than lower them in the United States. The flaw arises because manufacturers could postpone launching new drugs in foreign markets,...
Cerebral, a large integrated mental‑health provider, has acquired Inflow, a CBT‑based digital therapeutic app for adult ADHD, though financial terms were not disclosed. Inflow delivers short, science‑backed daily modules and is supported by an eight‑week randomized controlled trial showing significant...
This book explains how disruptive technologies and emerging trends such as robotics, artificial intelligence, 3D printing, precision medicine or patient design will impact the manufacturing and distribution of pharmaceuticals in order to prepare successfully for a better future of healthcare. Everything...
Teared up watching In Waves and War last night. Every day ~20 vets commit suic*de. Heartbreaking. The doc showcases ibogaine’s massively positive benefits for three troubled navy seals. Unfortunately it’s illegal in the US but ketamine isn’t and has had similar...
Regulatory agencies have launched inspections of 49 firms suspected of distributing unauthorized weight‑loss drugs. The sweep underscores heightened scrutiny of the booming weight‑loss market and raises questions about compliance across the industry.
99% accuracy sounds impressive. But belief happens when clinicians see it firsthand. Trust is the real implementation strategy. Full interview: https://t.co/YKdRTovquF @HealthCatalyst #clinicalimprovement #HITSM https://t.co/UpRxxGdPEK
The free market (no government-granted patent monopolies) will make Ozempic affordable for tens of millions of people https://t.co/SYl5M82mux
Fan Pier Labs released an open‑source MyChart connector that automates login, 2FA, and exposes 35+ tools to read and write patient data via the web UI. Unlike official FHIR APIs, it can perform any action a patient can, including messaging providers and...
The majority of radiologists and 4 LLMs were unable to differentiate synthetic, deepfake scans from real ones https://t.co/aAJhP0cpfG @RSNA https://t.co/q0wdIKicK6
The real way to use AI for medicine is to build safety, accuracy and triage on top of the big models like OpenAI. Using these models directly can be harmful. With appropriate safeguards Ai performs much better than the median...
Seattle‑area clinic reSTART has opened a 16‑week residential detox program that treats technology overuse as a substance‑use disorder. The intensive regimen forces participants to abstain from internet, smartphones, gaming and other digital media, positioning the service at the forefront of...
The Readout newsletter contained this nugget today. The posting for Vinay Prasad's job at #FDA states applicants don't need to be vaccinated. USG job postings don't normally address vaccination status. Message to the MAHA base? Sign up for @statnews newsletters here: https://t.co/Q3BKEkVZs0
ImmuneBridge announced a $7.7 million second seed round, bringing its total seed capital to roughly $20 million, to commercialize its proprietary cell‑therapy screening and manufacturing platform for external partners. The platform combines machine‑learning‑driven donor selection with a unique small‑molecule that preserves stem‑cell...
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases have engineered a dual‑action antibody that simultaneously targets two stages of Venezuelan equine encephalitis virus (VEEV) entry. The single‑molecule treatment protected animals even when given after exposure and neutralized...
